Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Globifer Forte in Chronic Heart Failure Patients With Iron Deficiency
2013-004704-19Phase 4Unknown
- Sponsor
- King's College London
- Start
- Nov 2015
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of GlobiFer in chronic heart failure (CHF) and iron deficiency anemia (IDA) (3 arms), sponsored by King's College London. Primary endpoint: 6-minute walk distance at week 12 (Globifer Forte vs placebo). Status: unknown.
02
Drugs
GlobiFer
03
Conditions
chronic heart failure (CHF)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2013-004704-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004704-19.